Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin.

Authors :: Steward T
Source :: Trends in molecular medicine [Trends Mol Med] 2024 Apr; Vol. 30 (4), pp. 321-323. Date of Electronic Publication: 2023 Dec 19.
Publication Year :: 2024
Abstract: The neurobiology of eating disorders [EDs; anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED)] remains poorly understood. Here, I describe how neuroimaging, accompanied by peripheral endocrine measures, can provide insights into the neurobiological drivers of eating disorders. Orexins/hypocretins, glucagon-like peptide-1 receptor (GLP1R) agonists, and psilocybin are highlighted as avenues for investigation.<br />Competing Interests: Declaration of interests The author has no conflicts of interest to declare.<br /> (Copyright © 2023 Elsevier Ltd. All rights reserved.)

Subjects :: Humans
Neuroimaging
Orexins therapeutic use
Psilocybin therapeutic use
Glucagon-Like Peptide-1 Receptor agonists
Binge-Eating Disorder diagnostic imaging
Binge-Eating Disorder drug therapy
Feeding and Eating Disorders diagnostic imaging
Feeding and Eating Disorders drug therapy

Full Text Access

Tools